156 related articles for article (PubMed ID: 32341757)
1. Targeted alpha therapy using astatine (
Watabe T; Kaneda-Nakashima K; Shirakami Y; Liu Y; Ooe K; Teramoto T; Toyoshima A; Shimosegawa E; Nakano T; Kanai Y; Shinohara A; Hatazawa J
Oncotarget; 2020 Apr; 11(15):1388-1398. PubMed ID: 32341757
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of new α-radionuclide therapy targeting LAT1: 2-[
Ohshima Y; Suzuki H; Hanaoka H; Sasaki I; Watanabe S; Haba H; Arano Y; Tsushima Y; Ishioka NS
Nucl Med Biol; 2020; 90-91():15-22. PubMed ID: 32916470
[TBL] [Abstract][Full Text] [Related]
3. L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors.
Nawashiro H; Otani N; Shinomiya N; Fukui S; Ooigawa H; Shima K; Matsuo H; Kanai Y; Endou H
Int J Cancer; 2006 Aug; 119(3):484-92. PubMed ID: 16496379
[TBL] [Abstract][Full Text] [Related]
4. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
[TBL] [Abstract][Full Text] [Related]
5. Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2.
Aoki M; Watabe T; Nagamori S; Naka S; Ikeda H; Kongpracha P; Horitsugi G; Kanai Y; Shimosegawa E; Kanai Y; Hatazawa J
Ann Nucl Med; 2019 Jun; 33(6):394-403. PubMed ID: 30820863
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of transport mechanisms of trans-1-amino-3-[¹⁸F]fluorocyclobutanecarboxylic acid and L-[methyl-¹¹C]methionine in human glioma cell lines.
Ono M; Oka S; Okudaira H; Schuster DM; Goodman MM; Kawai K; Shirakami Y
Brain Res; 2013 Oct; 1535():24-37. PubMed ID: 23994214
[TBL] [Abstract][Full Text] [Related]
7. BCH, an inhibitor of system L amino acid transporters, induces apoptosis in cancer cells.
Kim CS; Cho SH; Chun HS; Lee SY; Endou H; Kanai Y; Kim DK
Biol Pharm Bull; 2008 Jun; 31(6):1096-100. PubMed ID: 18520037
[TBL] [Abstract][Full Text] [Related]
8. System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells.
Kim DK; Kim IJ; Hwang S; Kook JH; Lee MC; Shin BA; Bae CS; Yoon JH; Ahn SG; Kim SA; Kanai Y; Endou H; Kim JK
Neurosci Res; 2004 Dec; 50(4):437-46. PubMed ID: 15567481
[TBL] [Abstract][Full Text] [Related]
9. Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranostics.
Kaizuka Y; Suzuki H; Watabe T; Ooe K; Toyoshima A; Takahashi K; Sawada K; Iimori T; Masuda Y; Uno T; Kannaka K; Uehara T
EJNMMI Radiopharm Chem; 2024 Feb; 9(1):17. PubMed ID: 38407647
[TBL] [Abstract][Full Text] [Related]
10. Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats.
Samnick S; Richter S; Romeike BF; Heimann A; Feiden W; Kempski O; Kirsch CM
Eur J Nucl Med; 2000 Oct; 27(10):1543-51. PubMed ID: 11083545
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of D-isomer of
Hirai N; Watabe T; Nagamori S; Wiriyasermkul P; Tanaka Y; Romanov V; Naka S; Kanai Y; Liu Y; Tani N; Sakai T; Tatsumi M; Shimosegawa E; Kanai Y; Hatazawa J
Asia Ocean J Nucl Med Biol; 2020; 8(2):102-108. PubMed ID: 32714997
[TBL] [Abstract][Full Text] [Related]
12.
Watabe T; Ikeda H; Nagamori S; Wiriyasermkul P; Tanaka Y; Naka S; Kanai Y; Hagiwara K; Aoki M; Shimosegawa E; Kanai Y; Hatazawa J
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):321-331. PubMed ID: 27550420
[TBL] [Abstract][Full Text] [Related]
13. (18)F-FBPA as a tumor specific tracer of L-type amino acid transporter 1 (LAT1): PET evaluation in tumor and inflammation compared to (18)F-FDG and (11)C-methionine.
Watabe T; Hatazawa J
Hell J Nucl Med; 2015; 18 Suppl 1():149. PubMed ID: 26665232
[TBL] [Abstract][Full Text] [Related]
14. Predominant contribution of L-type amino acid transporter to 4-borono-2-(18)F-fluoro-phenylalanine uptake in human glioblastoma cells.
Yoshimoto M; Kurihara H; Honda N; Kawai K; Ohe K; Fujii H; Itami J; Arai Y
Nucl Med Biol; 2013 Jul; 40(5):625-9. PubMed ID: 23557719
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of
Watabe T; Kaneda-Nakashima K; Liu Y; Shirakami Y; Ooe K; Toyoshima A; Shimosegawa E; Fukuda M; Shinohara A; Hatazawa J
J Nucl Med; 2019 Sep; 60(9):1301-1307. PubMed ID: 30796173
[No Abstract] [Full Text] [Related]
16. α-Emitting cancer therapy using
Kaneda-Nakashima K; Zhang Z; Manabe Y; Shimoyama A; Kabayama K; Watabe T; Kanai Y; Ooe K; Toyoshima A; Shirakami Y; Yoshimura T; Fukuda M; Hatazawa J; Nakano T; Fukase K; Shinohara A
Cancer Sci; 2021 Mar; 112(3):1132-1140. PubMed ID: 33277750
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of (111)In-labeled macrocyclic chelator-amino acid derivatives for cancer imaging.
Lee JJ; Shetty D; Lee YS; Kim SE; Kim YJ; Hong MK; Son JY; Jeong JM
Nucl Med Biol; 2012 Apr; 39(3):325-33. PubMed ID: 22136890
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and comparative biological evaluation of L- and D-isomers of 18F-labeled fluoroalkyl phenylalanine derivatives as tumor imaging agents.
Wang L; Lieberman BP; Plössl K; Qu W; Kung HF
Nucl Med Biol; 2011 Apr; 38(3):301-12. PubMed ID: 21492778
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of an
Yang X; Liu Z; Zhang H; Li Z; Munasinghe JP; Niu G; Teng G; Chen X
Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):585-592. PubMed ID: 29285548
[TBL] [Abstract][Full Text] [Related]
20. Differential expression and functional characterization of system L amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells.
Kim SG; Kim HH; Kim HK; Kim CH; Chun HS; Kanai Y; Endou H; Kim DK
Anticancer Res; 2006; 26(3A):1989-96. PubMed ID: 16827134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]